Cidofovir · more major-labeled pairs than Emtricitabine/Tenofovir
SPL labels Emtricitabine/Tenofovir + Cidofovir as minor; Emtricitabine/Tenofovir 9 / Cidofovir 11 in that band.
Mechanism on file: Taking these drugs together can increase the amount of medicine in your blood because they both leave the body through the kidneys. This can put extra stress on your kidneys and increase the risk of side effects.
FDA SPL severity: Minor
Emtricitabine/Tenofovir + Cidofovir · SPL mechanism field
Taking these drugs together can increase the amount of medicine in your blood because they both leave the body through the kidneys. This can put extra stress on your kidneys and increase the risk of side effects.
Minor band excerpt · Emtricitabine/Tenofovir with Cidofovir
Some examples include, but are not limited to, acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.3) ] .
Emtricitabine/Tenofovir · 9 minor + 9 total pairs
- Acyclovir minor
- Darunavir minor
- Ganciclovir minor
- Gentamicin minor
Cidofovir · 5 major-labeled pairs (vs Emtricitabine/Tenofovir's 0)
- Acetaminophen minor
- Acyclovir minor
- Bictegravir/Emtricitabine/Tenofovir minor
- Bumetanide minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.